These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 1839474)
1. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits. Agnelli G; Pascucci C; Cosmi B; Nenci GG Thromb Haemost; 1991 Nov; 66(5):592-7. PubMed ID: 1839474 [TBL] [Abstract][Full Text] [Related]
2. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits. Agnelli G; Pascucci C; Cosmi B; Nenci GG Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121 [TBL] [Abstract][Full Text] [Related]
3. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138 [TBL] [Abstract][Full Text] [Related]
4. Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits. Muñoz MC; Montes R; Hermida J; Orbe J; Páramo JA; Rocha E Br J Haematol; 1999 Apr; 105(1):117-21. PubMed ID: 10233373 [TBL] [Abstract][Full Text] [Related]
5. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin. Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336 [TBL] [Abstract][Full Text] [Related]
7. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model. Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787 [TBL] [Abstract][Full Text] [Related]
8. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis. Parise P; Morini M; Agnelli G; Ascani A; Nenci GG Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits. Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501 [TBL] [Abstract][Full Text] [Related]
11. Effects of therapeutic doses of heparin on thrombolysis with tissue-type plasminogen activator in rabbits. Agnelli G; Pascucci C; Cosmi B; Nenci GG Blood; 1990 Nov; 76(10):2030-6. PubMed ID: 2122919 [TBL] [Abstract][Full Text] [Related]
12. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality. Paloma MJ; Páramo JA; Rocha E Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240 [TBL] [Abstract][Full Text] [Related]
13. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site. Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727 [TBL] [Abstract][Full Text] [Related]
14. Standard and low molecular weight heparin have no effect on tissue plasminogen activator induced plasma clot lysis or fibrinogenolysis. Weitz JI; Kuint J; Leslie B; Hirsh J Thromb Haemost; 1991 May; 65(5):541-4. PubMed ID: 1651568 [TBL] [Abstract][Full Text] [Related]
15. The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits. Van Ryn-McKenna J; Merk H; Müller TH; Buchanan MR; Eisert WG Thromb Haemost; 1993 Mar; 69(3):227-30. PubMed ID: 8470045 [TBL] [Abstract][Full Text] [Related]
16. Prevention of thrombus growth by antithrombin III-dependent and two direct thrombin inhibitors in rabbits: implications for antithrombotic therapy. Brill-Edwards P; Van Ryn-McKenna J; Cai L; Ofosu FA; Buchanan MR Thromb Haemost; 1992 Oct; 68(4):424-7. PubMed ID: 1448774 [TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways. Munkvad S Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763 [TBL] [Abstract][Full Text] [Related]
18. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis. van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459 [TBL] [Abstract][Full Text] [Related]
19. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model]. Kawakami K; Takahashi A; Yoshimoto T No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401 [TBL] [Abstract][Full Text] [Related]
20. Effect of a selective thrombin inhibitor MCI-9038 on fibrinolysis in vitro and in vivo. Tamao Y; Yamamoto T; Kikumoto R; Hara H; Itoh J; Hirata T; Mineo K; Okamoto S Thromb Haemost; 1986 Aug; 56(1):28-34. PubMed ID: 2877508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]